Sign In
NewsRadar

Index Ventures

A European technology venture capital fund.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
2, rue de Jargonnant
Geneva 1207
Switzerland
+41 22 737 0000
+41 22 737 0099
http://www.indexventures.com
Pascal Jouin
+41 22 737 0047

Company Facts
Type:
Capital managed:
Companies invested in:  
Investment managers:
Total staff size:
Number of offices:
Min. investment size:
Max. investment size:
Independent Investor (VC)
500 Mln Euro
36
12
24
1
2 Mln Euro
20 Mln Euro
Funding stages:Startups, Early Stages, Expansion
Geo. scope europe:North Europe, West Europe, South Europe
Investment distrib.:Europe 75%, USA 25%
Industry preferences:Internet, Communications, Computer Related, Software, Other

Partners

  • Bernard Dallé
  • David Rimer
  • Francesco De Rubertis
  • Giuseppe Zocco
  • Neil Rimer

    Portfolio

  • Cellzome (acquired by GlaxoSmithKline)
  • 7TM Pharma A/S
  • Virata
  • SCM Microsystems
  • Optimer
  • Neo Vista Software
  • GeneBio
  • Evolve Software
  • ControlMed
  • CommQuest Technologies
  • Calico Commerce
  • ArrayComm
  • Aptix
  • Webfair AG
  • Vitaminic
  • The Fantastic Corporation
  • Structural GenomiX
  • StepStone
  • smarterwork.com
  • Respond.com
  • Ofoto
  • Numerical Technologies, Inc.
  • Mediasurface Limited
  • Listen.com
  • LaserComm
  • Ingenium Pharmaceuticals
  • Genmab
  • Flutter
  • Evolve Software
  • DirectMedica
  • digiquant
  • ciao.com AG (Acquired by Greenfield Online Inc)

    Funds
    NameStatusClosingSize
    Index Ventures IVClosedFeb 2007350 Mln Euro
    Index Ventures IIIClosedFeb 2005300 Mln Euro
    Index Ventures II LPClosedJun 2001300 Mln USD
    Index Ventures I LPClosedNov 1998180 Mln USD
    Index Ventures 0 LPClosedApr 199615 Mln USD

    Remarks
    In the field of IT, Index Ventures currently invests in the following markets: enterprise software, data communications,telecommunications, computing and storage. Within health care, Index focuses on genomics, proteomics, drug discovery platforms, drug delivery mechanisms, monoclonal antibodies as well as cost-containment and disease management.


  • Data


    25,099
    Tech investments
    From our Online Data Service
    16,240
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Dec 7€6.3MNanotechnology
    Dec 7€21.1MInternet commerce
    Dec 7€4.8MInternet commerce
    Dec 7€1.8MInternet commerce
    Dec 6N/AInternet commerce
    Dec 6€26.0MBusiness applications
    Dec 6€5.6MMedical devices

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises 1m in seed funding to build tech-enabled home ...

    Aug 17
    Komed Health
    komed health closes seed financing round

    Jul 10
    Komed Health
    komed health to be supported by nokia and deutsche telekom





    About usContact usLegal Information
    Copyright 1999-2018
    Emerging Technology Research Europe Inc. All rights reserved.